The Society of Hematologic Oncology (SOHO)
Hagop M. Kantarjian
What is the rationale for novel combination therapies?
Niels van de Donk
Exploiting signalling pathways involved in CLL to develop novel therapies
Do we need to stratify follicular lymphoma (FL) patients for treatment?
Inspired by the EBMT Nurses Group: the potential for a BMT Nurses Group in India